Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ACADIA Pharmaceuticals Inc. (ACAD)

« Back to company index

ACAD Chatter Timeline

Stock Ticker for ACAD

Most Active Tweeters for ACAD

UserTweets
@ForTheRecord01 20
@Tickeron 6
@Estimize 4
@Soudesu9 4
@TradeWithAlerts 4

Recent Tweets for ACAD

SeekingAlpha @SeekingAlpha
$ACAD - ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q2 2021 Results - Earnings Call Transcript.… https://t.co/nt0BYp6LdP
4:08am
drbeckler @drbeckler
Hmm, buying on the dip? $ACAD
2:08am
bearcapital1 @bearcapital1
CNS companies need to come up with more unique approaches then just making patients tired. $ACAD ?
1:08am
bearcapital1 @bearcapital1
$ACAD at 3.3B I think is meh and no opinion on $FGEN at 1.2B but does it really cost 4.5B to walk away with these f… https://t.co/SOr63Y3GYg
1:08am
newsfilterio @newsfilterio
ACADIA Pharma slides after 2021 guidance lagged expectations $ACAD https://t.co/AN6mE1sxbD
12:08am
Soudesu9 @Soudesu9
$acad put a fork in it
August 4th 2021, 10:08pm
saltadogato @saltadogato
Goodman getting right to the point $ACAD https://t.co/mUSkvWGpML
August 4th 2021, 10:08pm
ForTheRecord01 @ForTheRecord01
$ACAD On today's call, not one analyst asked the execs about appealing the Psych Division's decision (and stall tac… https://t.co/PctquCGmrG
August 4th 2021, 10:08pm
ForTheRecord01 @ForTheRecord01
17 months have passed since $ACAD held its pre-sNDA meeting with the FDA. You'd never know so much time has been l… https://t.co/WLgCKvKoAk
August 4th 2021, 10:08pm
Briefingcom @Briefingcom
$ACAD: ACADIA Pharmaceuticals beats by $0.03, misses on revs; guides FY21 revs below consensus https://t.co/8WkpBiiWRT
August 4th 2021, 10:08pm
ForTheRecord01 @ForTheRecord01
$ACAD If the FDA had any concerns about the efficacy of pimanvaserin in dementia-related psychosis, why didn't the… https://t.co/0e1ZB2A8Gu
August 4th 2021, 9:08pm
ethanFlare @ethanFlare
$ACAD - ACADIA Pharma slides after 2021 guidance lagged expectations Cap size: mid, Float 73.3%, Short Interest 6.8… https://t.co/xpuHrhzAIv
August 4th 2021, 9:08pm
mehabecapital @mehabecapital
(Earnings) ACADIA ( $ACAD ) Actual.EPS=-0.27 vs Est.EPS=-0.3044, Actual.Rev=115.2M vs Est.Rev=124.9M, Last Quote: $… https://t.co/ywymW921Be
August 4th 2021, 8:08pm
mediasentiment @mediasentiment
$ACAD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1158
August 4th 2021, 8:08pm
mediasentiment @mediasentiment
$ACAD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1156
August 4th 2021, 8:08pm
Soudesu9 @Soudesu9
$acad sell the company for $25 a share
August 4th 2021, 8:08pm
Estimize @Estimize
This afternoon's winner for $ACAD is Needham_45 who beats 6 other analysts and the Wall Street Consensus - https://t.co/dbf26mYZgT
August 4th 2021, 8:08pm
Estimize @Estimize
$ACAD beats the Estimize EPS Consensus by 3c and misses the Estimize Revenue Consensus by $10.14M. Reports FQ2 earn… https://t.co/IRzHycZd4f
August 4th 2021, 8:08pm
Estimize @Estimize
$ACAD reports FQ2 earnings of -27c EPS and $115.22M Revs - https://t.co/SRP81Hso2i
August 4th 2021, 8:08pm
ForTheRecord01 @ForTheRecord01
Is $ACAD even aware that the acting FDA commissioner has called for an investigation of her own agency? https://t.co/Zi5TAo2okQ
August 4th 2021, 8:08pm
mehabecapital @mehabecapital
$ACAD @ 21.05 - ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered https://t.co/tvfpBWLohq
August 4th 2021, 8:08pm
ForTheRecord01 @ForTheRecord01
If $ACAD cared about its shareholders at all, it would appeal the recent FDA decision immediately. Nuplazid should… https://t.co/OJu3oUvJA7
August 4th 2021, 8:08pm
ForTheRecord01 @ForTheRecord01
In a staggering show of generosity, the FDA told $ACAD it is willing to reconsider its opinion on the DRP sNDA "som… https://t.co/EGaQotLMoM
August 4th 2021, 8:08pm
ethanFlare @ethanFlare
$ACAD - ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered Cap size: mid, Float 73.3%, Shor… https://t.co/F3stQhUgvJ
August 4th 2021, 8:08pm
fintel_io @fintel_io
Also, if you are new to $ACAD here's a background article on Finpedia for you https://t.co/Chy0RZypJd
August 4th 2021, 8:08pm
DoctorSPAC @DoctorSPAC
$ACAD - bad print.
August 4th 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$ACAD [15s. delayed, acc.~90%, always check] Earnings Release August 04, 16:05:00: Q2: GAAP EPS of -$0.27, Revenue… https://t.co/mFHfaeeLZP
August 4th 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$ACAD [15s. delayed]: Issued Press Release on August 04, 16:05:00: Acadia Pharmaceuticals Reports Second Quarter 20… https://t.co/Gc5gaZ7UnT
August 4th 2021, 8:08pm
Sports_bios @Sports_bios
$ACAD type A mtg - FDA repeats the same stance on subgrp DRP - but they are open to yet another mtg - /// gee..
August 4th 2021, 8:08pm
bthefirsttoknow @bthefirsttoknow
$ACAD: Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results //First out https://t.co/y6SUk6bJqP
August 4th 2021, 8:08pm
StockPods @StockPods
$ACAD Earnings Call Today: 4:30 PM EST Webcast: https://t.co/wHggeEt5h9 Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99
August 4th 2021, 6:08pm
EPSGUID @EPSGUID
Options are priced for bigger-than-average #earnings move for $ACAD reporting after close via @eWhispers #volatility https://t.co/I0UQKwthar
August 4th 2021, 6:08pm
piqueing @piqueing
Who else is keenly waiting for the $ACAD news today?
August 4th 2021, 6:08pm
Estimize @Estimize
$ACAD reports after the close, Estimize Consensus +0 EPS and +0.46M Revs compared to WS - https://t.co/dEPtNEgtVM
August 4th 2021, 3:08pm
TipRanks @TipRanks
$ACAD ACADIA: The Street’s Gaze Turns to FDA Meeting’s Outcome on DRP Treatment https://t.co/BMfv7wrLyp
August 3rd 2021, 11:08pm
MarketCurrents @MarketCurrents
$ACAD - ACADIA Pharma Q2 2021 Earnings Preview https://t.co/PnCPzNamh6
August 3rd 2021, 9:08pm
Tickeron @Tickeron
Acadia Pharmaceuticals Inc to report earnings on August 04, 2021. Earnings per share (EPS) estimate: $-0.30 $ACAD… https://t.co/yX4kjjRoyk
August 3rd 2021, 7:08pm
ChartMill @ChartMill
$ACAD shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.14%. https://t.co/KWWNp7ypOe https://t.co/eBa25Fx2en
August 3rd 2021, 3:08pm
mehabecapital @mehabecapital
$ACAD in Double Bottom formation , quote @ 20.83 https://t.co/x8qLKHeVOK
August 3rd 2021, 2:08pm
Soudesu9 @Soudesu9
$acad no news is bad news
August 3rd 2021, 1:08pm
Adrian97707834 @Adrian97707834
Disapointed because of losses? What doesn't kill you makes you stronger! BUYSIGN001 has no emotions trading $ACAD,… https://t.co/aLlviLY0cA
August 3rd 2021, 11:08am
Adrian97707834 @Adrian97707834
Don't forget your loss-cuts! BUYSIGN001 delivers performance trading $ACAD through consistent loss-cuts execution.… https://t.co/QUPfYkL3EC
August 3rd 2021, 11:08am
Soudesu9 @Soudesu9
$acad wtf…not a lot of confidence going into earnings
August 2nd 2021, 6:08pm
tradersreport @tradersreport
RT @Tickeron: $ACAD's 10-day Moving Average crossed below its 50-day Moving Average on July 19, 2021. View odds for this and other indicato…
August 2nd 2021, 5:08pm
Tickeron @Tickeron
$ACAD's 10-day Moving Average crossed below its 50-day Moving Average on July 19, 2021. View odds for this and othe… https://t.co/3fBHTo2ryB
August 2nd 2021, 5:08pm
ShortAlgoTrades @ShortAlgoTrades
$ACAD Awaiting buy signal ! https://t.co/PMTRKxMDqn
August 2nd 2021, 4:08pm
ShortAlgoKing @ShortAlgoKing
$ACAD Awaiting buy signal ! https://t.co/Vc6u8iCdOL
August 2nd 2021, 4:08pm
saltadogato @saltadogato
So $ACAD is likely giving us an update on their type A meeting on Wednesday - given how the stock has been trading,… https://t.co/Qxror0ERNW
August 2nd 2021, 3:08pm
Gambiste1 @Gambiste1
RT @Sports_bios: $ACAD much like the SRPT case, the top Q people will ask is - any update from the type A mtg w/ FDA post CRL w/ DRP - what…
August 2nd 2021, 2:08pm
Sports_bios @Sports_bios
$ACAD much like the SRPT case, the top Q people will ask is - any update from the type A mtg w/ FDA post CRL w/ DRP… https://t.co/xHk1wHWqgz
August 2nd 2021, 1:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.